secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch Health Companies Inc. (BHC)
CIK:        0000885590
Form:       8-K
Filed at:   2025-07-24T23:59:59+00:00
Accession:  0001193125-25-163860
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch Health appoints Michael Goettler and Sandra Leung to Board, effective July 22, 2025
--------------------------------------------------------------------------------

- Board expands from 10 to 12 members with the addition of two new directors.
- Michael Goettler, former Viatris CEO, joins Talent & Compensation and Science & Technology Committees.
- Sandra Leung, former BMS EVP & General Counsel, joins Nominating & Corporate Governance Committee.
- Both appointees have extensive pharmaceutical industry leadership experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/885590/000119312525163860/0001193125-25-163860-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/885590/000119312525163860/d862655d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-163860

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer